Fennec Pharmaceuticals (FENC) Other Non-Current Assets (2021 - 2025)
Fennec Pharmaceuticals posted quarterly Other Non-Current Assets of $717000.0 for Q4 2025, down 12.77% year-on-year from $822000.0 in Q4 2024, and down 3.5% on a QoQ basis from $743000.0 in Q3 2025.
Fennec Pharmaceuticals (FENC) has 5 years of Other Non-Current Assets data on file, last reported at $717000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Non-Current Assets fell 12.77% year-over-year to $717000.0; the trailing twelve-month figure through Dec 2025 stood at $717000.0 (down 12.77% YoY), and the FY2025 full-year result was $717000.0, down 12.77% from the prior year.
- Other Non-Current Assets for Q4 2025 stood at $717000.0, down from $743000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $1.0 million in Q1 2024 and bottomed at $14000.0 in Q2 2022.
- The 5-year median for Other Non-Current Assets is $730000.0 (2025), against an average of $526812.5.
- The widest annual swing landed in 2024, when Other Non-Current Assets soared 833.02%; it then slipped 22.35% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $27000.0 in 2021, then soared by 681.48% to $211000.0 in 2022, then soared by 286.73% to $816000.0 in 2023, then rose by 0.74% to $822000.0 in 2024, then decreased by 12.77% to $717000.0 in 2025.
- The last three Other Non-Current Assets figures came in at $717000.0 (Q4 2025), $743000.0 (Q3 2025), and $768000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.13 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 63.55 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | 717,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 717,000.00 |
| Sep 30, 2025 | 743,000.00 |
| Jun 30, 2025 | 768,000.00 |
| Mar 31, 2025 | 794,000.00 |
| Dec 31, 2024 | 822,000.00 |
| Sep 30, 2024 | 956,000.00 |
| Jun 30, 2024 | 989,000.00 |
| Mar 31, 2024 | 1.02 Mn |
| Dec 31, 2023 | 816,000.00 |
| Jun 30, 2023 | 106,000.00 |
| Mar 31, 2023 | 159,000.00 |
| Dec 31, 2022 | 211,000.00 |
| Sep 30, 2022 | 264,000.00 |
| Jun 30, 2022 | 14,000.00 |
| Mar 31, 2022 | 21,000.00 |
| Dec 31, 2021 | 27,000.00 |